Home › Funds › Financially Speaking Inc › GILD

Financially Speaking Inc position in GILD

GILEAD SCIENCES INC · Health Care

Financially Speaking Inc reported holding 158 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$22K, representing 0.11% of its reported portfolio and ranking #47 among its reported holdings. Financially Speaking Inc has disclosed GILD holdings in 7 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)158 sh
Reported value held$22.02K
Portfolio Weight0.11%
First reportedQ4 2024
Last changeHold
Updated2026-11-04

Last updated: 2026-11-04 · Source: SEC EDGAR Form 13F-HR

How Financially Speaking Inc's GILD position evolved

Financially Speaking Inc first disclosed a stake in GILD in Q4 2024 at 540 shares (US$50K). Across 7 filings, Financially Speaking Inc increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 158 shares valued at US$22K.

Quarter by quarter

QuarterSharesValueChange
Q4 2024 540 $49.88K New
Q2 2025 182 $20.18K New
Q3 2025 182 $20.20K Hold
Q4 2025 182 $22.34K Hold
Q1 2026 158 $22.02K Reduce
Q2 2026 158 $22.02K Hold
Q3 2026 158 $22.02K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has Financially Speaking Inc held GILD?

Financially Speaking Inc has disclosed GILD holdings in 7 of the last 8 reported quarters, going back to Q4 2024.

What is Financially Speaking Inc's current position in GILD?

As of Q3 2026, Financially Speaking Inc holds 158 shares of GILD (GILEAD SCIENCES INC), valued at $22.02K, representing 0.11% of its reported portfolio and ranking #47.

Has Financially Speaking Inc been buying or selling GILD?

In the latest 13F filing (Q3 2026), Financially Speaking Inc held unchanged its position in GILD.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.